Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme.
Stanley B CohenRonald F Van VollenhovenKevin L WinthropCristiano A F ZerbiniYoshiya TanakaLouis BessetteYing ZhangNasser KhanBarbara HendricksonJeffrey V EnejosaGerd R BurmesterPublished in: Annals of the rheumatic diseases (2020)
SELECT-EARLY: NCT02706873; SELECT-NEXT: NCT02675426; SELECT-COMPARE: NCT02629159; SELECT-MONOTHERAPY: NCT02706951; SELECT-BEYOND: NCT02706847.